Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 07, 2020
Abzena has announced upgrades to its chemistry GMP suites.
read more
Friday, December 04, 2020
CureVac and Wacker Chemie have signed a contract for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV.
read more
Thursday, December 03, 2020
Idifarma has announced a partnership with Stefano Console from Swiss life sciences consultancy Oriento.
read more
Wednesday, December 02, 2020
Bora Pharmaceuticals announced the CDMO has successfully completed the acquisition of GSK’s Mississauga, Ontario facility.
read more
Wednesday, December 02, 2020
Jay Feldman has joined Pharmaceutics International, Inc. (Pii) as the Head of Information Technology.
read more
Wednesday, December 02, 2020
Lonza has announced additional investments in its oral drug product development and manufacturing capabilities at its Tampa, Florida site.
read more
Wednesday, December 02, 2020
WuXi Advanced Therapies announced the completion of a facility expansion that will triple its advanced testing capacity at the company's Philadelphia Navy Yard campus.
read more
Tuesday, December 01, 2020
Catalent announced the appointment of Behzad Mahdavi, Ph.D., MBA, as Vice President of Open Innovation, Biologics, Cell and Gene Therapy.
read more
Tuesday, December 01, 2020
Mustang Bio and Minaris have signed an agreement to enable technology transfer and GMP clinical manufacturing of Mustang’s MB-107 lentiviral gene therapy program for the treatment of XSCID in Europe.
read more
Monday, November 30, 2020
ProBioGen announced the closing of a master service agreement with Asahi Kasei Pharma.
read more
Wednesday, November 25, 2020
Bionova Scientific announced it has secured its first client commitment for GMP clinical supply.
read more
Wednesday, November 25, 2020
Cambrex is expanding its mid-scale and large-scale API manufacturing capacity in Charles City, Iowa.
read more
Tuesday, November 24, 2020
Samsung Biologics' partnership with Eli Lilly and Company is expected to accelerate the global supply for Lilly's COVID-19 antibody therapies through a long-term manufacturing agreement.
read more
Monday, November 23, 2020
Onyx Scientific announced it is investing in a new facility at its UK site in order to prepare for the approval of a commercial API license.
read more
Monday, November 23, 2020
CCRM and MIP have signed a LOI to partner in the development of a biomanufacturing campus at MIP focused on regenerative medicine-based technologies and cell and gene therapies.
read more